| (20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP (3.3 G) | 00438014 | Marketed | Baxter Corporation | Jan 2013 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP (5 G) | 00786292 | Marketed | Baxter Corporation | Jan 2013 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP (5 G) | 00438049 | Marketed | Baxter Corporation | Jan 2013 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP (5 G) | 00437999 | Marketed | Baxter Corporation | Jan 2013 |
| (40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP (5 G) | 00438030 | Marketed | Baxter Corporation | Jan 2013 |
| (40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP (3.3 G) | 00438022 | Marketed | Baxter Corporation | Jan 2013 |
| (40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP (5 G) | 00438006 | Marketed | Baxter Corporation | Jan 2013 |
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP (5 G) | 01931598 | Marketed | B. Braun Medical AG | Oct 1998 |
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION (50 MG) | 00828602 | Marketed | Baxter Corporation | Dec 2019 |
| 10% DEXTROSE INJECTION USP (100 MG) | 01924427 | Marketed | B. Braun Medical AG | Apr 1998 |
| 10% DEXTROSE INJECTION, USP (10 G) | 00060364 | Marketed | Baxter Corporation | Mar 2019 |
| 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP (5 G) | 01927531 | Marketed | B. Braun Medical AG | May 1998 |
| 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP (50 MG) | 01924435 | Marketed | B. Braun Medical AG | May 1998 |
| 5% DEXTROSE INJECTION USP (50 MG) | 01924281 | Marketed | B. Braun Medical AG | Apr 1998 |
| 5% DEXTROSE INJECTION, USP (5 G) | 00060348 | Marketed | Baxter Corporation | Mar 2019 |
| 70% DEXTROSE INJECTION USP (70 G) | 02014874 | Marketed | Baxter Corporation | Jan 2015 |
| ACID CONCENTRATE 2156 (90 G) | 02239491 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE 2182 (89.99 G) | 02210835 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE A1221 (49.5 G) | 02254344 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1222 (49.5 G) | 02254336 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1223 (49.5 G) | 02254328 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1224 (49.5 G) | 02254301 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1225 (49.5 G) | 02254298 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1226 (49.5 G) | 02254255 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1227 (49.5 G) | 02254247 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1228 (49.5 G) | 02533774 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1230 (74.25 G) | 02254085 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1231 (49.5 G) | 02533855 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1241 (49.5 G) | 02533782 | Marketed | Chief Medical Supplies Ltd | Feb 2023 |
| ACID CONCENTRATE A1242 (49.5 G) | 02533847 | Marketed | Chief Medical Supplies Ltd | Feb 2023 |
| ACID CONCENTRATE A1243 (49.5 G) | 02533758 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1245 (49.5 G) | 02533812 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1246 (49.5 G) | 02533820 | Marketed | Chief Medical Supplies Ltd | Feb 2023 |
| ACID CONCENTRATE A1252 (49.5 G) | 02533839 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1255 (49.5 G) | 02533766 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1261 (49.5 G) | 02262479 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1262 (49.5 G) | 02262487 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1263 (49.5 G) | 02533871 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1265 (49.5 G) | 02533863 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1266 (74.25 G) | 02262525 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1267 (49.5 G) | 02533898 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1270 (49.5 G) | 02272512 | Marketed | Chief Medical Supplies Ltd | Jan 2026 |
| ACID CONCENTRATE A1275 (49.5 G) | 02272563 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1277 (99 G) | 02272598 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1279 (49.5 G) | 02272628 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1294 (49.5 G) | 02268728 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1296 (49.49 G) | 02435918 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1297 (49.49 G) | 02435969 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1298 (49.49 G) | 02435950 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE D12201 (45 G) | 00860565 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12207 (45 G) | 00890197 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12236 (67.5 G) | 02217244 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12248 (90 G) | 02158329 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12262 (90 G) | 02158221 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12264 (45 G) | 02158159 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12272 (45 G) | 02178125 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12275 (45 G) | 02218879 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12286 (45 G) | 02217252 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12290 (90 G) | 02217643 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12291 (90 G) | 02217279 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12293 (45 G) | 02217554 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12294 (45 G) | 02217619 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12299 (67.5 G) | 02217260 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12300 (45 G) | 02217597 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12302 (45 G) | 02217635 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12305 (67.5 G) | 02217600 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12316 (90 G) | 02178168 | Marketed | Vantive Ulc | May 2024 |
| ADDITIVE SOLUTION SODIUM ADENINE GLUCOSE MANNITOL (SAGM) (9 G) | 02444097 | Marketed | Maco Pharma | Aug 2016 |
| ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A (2.45 G) | 00788139 | Marketed | Fresenius Kabi Ag | Mar 2018 |
| ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A (2.45 G) | 02469731 | Marketed | Terumo Bct, Inc. | Jun 2018 |
| ANTICOAGULANT SOLUTION CITRATE PHOSPHATE DEXTROSE (CPD) (25.5 G) | 02444100 | Marketed | Maco Pharma | Aug 2016 |
| AVL DEXTROSE SOLUTION 50% (50 %) | 02401401 | Marketed | Alberta Veterinary Laboratories Ltd | Oct 2022 |
| AVL ELECTROLYTE CONCENTRATE (27 G) | 02384655 | Marketed | Alberta Veterinary Laboratories Ltd | Mar 2014 |
| BALANCE 1.5% GLUCOSE, 1.25 MMOL/L CALCIUM (16.5 G) | 02261057 | Marketed | Fresenius Medical Care Canada Inc | Apr 2021 |
| BALANCE 2.3% GLUCOSE, 1.25 MMOL/L CALCIUM (25 G) | 02261073 | Marketed | Fresenius Medical Care Canada Inc | Apr 2021 |
| BALANCE 4.25% GLUCOSE, 1.25 MMOL/L CALCIUM (46.75 G) | 02261065 | Marketed | Fresenius Medical Care Canada Inc | May 2021 |
| BSS PLUS (0.092 %) | 00568082 | Marketed | Alcon Canada Inc. | Dec 1982 |
| CAL-MAG PLUS (15 %) | 02478552 | Marketed | Dmvet Inc | Nov 2018 |
| CALCI-MAG-PHOS-DEXTROSE (15 %) | 02518872 | Marketed | Alberta Veterinary Laboratories Ltd | Oct 2022 |
| CALF-LYTE II (41.734 G) | 02242113 | Marketed | Vetoquinol N A Inc | Sep 2000 |
| CALF-LYTE II HE (149.04 G) | 02242114 | Marketed | Vetoquinol N A Inc | Sep 2000 |
| CALF-QUENCH HE (149.04 G) | 02495775 | Marketed | Dominion Veterinary Laboratories Ltd. | Oct 2025 |
| CLINIMIX (5 G) | 02013886 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX (20 G) | 02013940 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX (16.6 G) | 02046709 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX (10 G) | 02013932 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX (5 G) | 02498448 | Marketed | Baxter Corporation | Apr 2022 |
| CLINIMIX (10 G) | 02498456 | Marketed | Baxter Corporation | Apr 2023 |
| CLINIMIX (14 G) | 02498464 | Marketed | Baxter Corporation | Nov 2020 |
| CLINIMIX E (10 G) | 02014076 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (16.6 G) | 02013967 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (10 G) | 02142384 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (10 G) | 02498413 | Marketed | Baxter Corporation | Oct 2021 |
| CLINIMIX E (14 G) | 02498421 | Marketed | Baxter Corporation | Dec 2020 |
| DEXTROSE 0.2% AND 0.9% SOD CHLOR SOLUTION (200 MG) | 00783641 | Marketed | Baxter Corporation | Dec 1991 |
| DEXTROSE 10% AND 0.9% SOD CHLORIDE INJ (10 G) | 00060755 | Marketed | Baxter Corporation | Dec 1990 |
| DEXTROSE 3.3% AND 0.3% SOD CHLORIDE INJ (3.3 G) | 00060712 | Marketed | Baxter Corporation | Dec 1990 |
| DEXTROSE 5% AND 0.2% SOD CHLORIDE INJ (5 G) | 00060704 | Marketed | Baxter Corporation | Dec 1990 |
| DEXTROSE 5% AND 0.45% SOD CHLORIDE INJ (5 G) | 00060739 | Marketed | Baxter Corporation | Dec 1990 |
| DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ (5 G) | 00060747 | Marketed | Baxter Corporation | Dec 1990 |
| DEXTROSE 50% STERILE INJECTION (50 %) | 00467618 | Marketed | Bimeda-MTC Animal Health Inc. | Oct 2002 |
| DEXTROSE INJECTION (50 %) | 02517132 | Marketed | Omega Laboratories Limited | Mar 2022 |
| DEXTROSE INJECTION USP (50 MG) | 00037915 | Marketed | Icu Medical Canada Inc | Nov 2019 |
| DEXTROSE INJECTION USP (500 MG) | 02468514 | Marketed | Pfizer Canada Ulc | Aug 2020 |
| DIANEAL PD101 CAPD SOLUTION WITH 0.5% DEXTROSE (500 MG) | 00799793 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD101 CAPD SOLUTION WITH 1.5% DEXTROSE (1.5 G) | 00799815 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD101 CAPD SOLUTION WITH 2.5% DEXTROSE (2.5 G) | 00799823 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD101 CAPD SOLUTION WITH 4.25% DEXTROSE (4.25 G) | 00799807 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM (1.5 G) | 00865095 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM (2.5 G) | 00865109 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM (4.25 G) | 00865117 | Marketed | Vantive Ulc | Apr 2024 |
| DMVÉT DEXTROSE 50% (50 %) | 02420880 | Marketed | Dmvet Inc | Oct 2014 |
| DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP (50 MG) | 00761850 | Marketed | Baxter Corporation | Dec 1992 |
| DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP (50 MG) | 00761826 | Marketed | Baxter Corporation | Dec 1990 |
| DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP (50 MG) | 00761834 | Marketed | Baxter Corporation | Dec 1990 |
| HEMOSATE ULTRA HS1125 (49.5 G) | 02413892 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS2125 (49.5 G) | 02413906 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS3125 (49.5 G) | 02413914 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS4125 (49.5 G) | 02413922 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ (5 G) | 02209713 | Marketed | B. Braun Medical AG | Jun 1998 |
| HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ (5 G) | 02209721 | Marketed | B. Braun Medical AG | Jun 1998 |
| HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML (5 G) | 01935941 | Marketed | B. Braun Medical AG | Sep 1998 |
| LACTATED RINGER'S AND 5% DEXTROSE INJECTION, USP (5 G) | 00061131 | Marketed | Baxter Corporation | Dec 1973 |
| LMD 10% IN DEXTROSE 5% (5 %) | 00224235 | Marketed | Pfizer Canada Ulc | Sep 2017 |
| NATURALYTE H-200 (98.99 G) | 02330172 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Oct 2020 |
| NATURALYTE H-201 (49.49 G) | 02330024 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Oct 2020 |
| NATURALYTE H-208 (49.49 G) | 02329980 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Nov 2020 |
| NATURALYTE H-225 (49.49 G) | 02327465 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-226 (49.49 G) | 02327406 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Sep 2020 |
| NATURALYTE H-229 (49.49 G) | 02326949 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-232 (49.49 G) | 02330253 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-260 (49.49 G) | 02327384 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Feb 2021 |
| NATURALYTE H-320 (49.49 G) | 02330229 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-330 (49.49 G) | 02327503 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-332 (49.49 G) | 02327333 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-401 (49.49 G) | 02327309 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-402 (49.49 G) | 02327422 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Sep 2020 |
| NATURALYTE H-408 (49.49 G) | 02327538 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Sep 2020 |
| NATURALYTE H-410 (49.49 G) | 02327511 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Oct 2020 |
| NATURALYTE H-616 (98.99 G) | 02327066 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Nov 2020 |
| NATURALYTE H-623 (74.28 G) | 02330016 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-624 (74.28 G) | 02330032 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NITROGLYCERIN IN 5% DEXTROSE INJ.-200MCG/ML (5 G) | 02145308 | Marketed | Baxter Corporation | Dec 1995 |
| NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML (5 G) | 02145316 | Marketed | Baxter Corporation | Dec 1995 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 304) (23.1 G) | 02363631 | Marketed | Nxstage Medical, Inc. | Nov 2013 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-301) (23.1 G) | 02363615 | Marketed | Nxstage Medical, Inc. | Dec 2013 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-302) (23.1 G) | 02363666 | Marketed | Nxstage Medical, Inc. | Jul 2013 |
| NXSTAGE PUREFLOW SOLUTION (1.1 G) | 02443279 | Marketed | Nxstage Medical, Inc. | Feb 2026 |
| NXSTAGE PUREFLOW SOLUTION (1.1 G) | 02443287 | Marketed | Nxstage Medical, Inc. | Feb 2026 |
| NXSTAGE PUREFLOW SOLUTION (1.1 G) | 02443295 | Marketed | Nxstage Medical, Inc. | Aug 2026 |
| OLIMEL 5.7% (121 G) | 02352540 | Marketed | Baxter Corporation | Sep 2019 |
| OLIMEL 5.7% E (121 G) | 02352532 | Marketed | Baxter Corporation | Jan 2011 |
| OLIMEL 7.6% (80.67 G) | 02477947 | Marketed | Baxter Corporation | Jul 2021 |
| OLIMEL 7.6% E (80.67 G) | 02477955 | Marketed | Baxter Corporation | Oct 2018 |
| PERIOLIMEL 2.5% E (82.50 G) | 02352494 | Marketed | Baxter Corporation | Feb 2011 |
| PHYSIONEAL 40 GLUCOSE 1.36% (37.5 G) | 02247721 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 1.36% CLEAR-FLEX (18.2 G) | 02368730 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 2.27% (62.6 G) | 02247722 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 2.27% CLEAR-FLEX (30.3 G) | 02368757 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 3.86% (106.5 G) | 02247723 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 3.86% CLEAR-FLEX (51.5 G) | 02368749 | Marketed | Vantive Ulc | May 2024 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR (5 G) | 00786306 | Marketed | Baxter Corporation | Dec 1990 |
| SCLERODEX (250 MG) | 02020939 | Marketed | Omega Laboratories Limited | Dec 1977 |
| SELECTBAG ONE (AX 125 G) (220 G) | 02414813 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 150 G) (220 G) | 02414821 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 225 G) (220 G) | 02414856 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 250 G) (220 G) | 02415461 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 2525 G) (220 G) | 02415496 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 325 G) (220 G) | 02414902 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 350 G) (220 G) | 02415526 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 450 G) (220 G) | 02415488 | Marketed | Vantive Ulc | May 2024 |
| SMOFKABIVEN (12.7 G) | 02440695 | Marketed | Fresenius Kabi Canada Ltd | Sep 2015 |
| SMOFKABIVEN ELECTROLYTE FREE (12.7 G) | 02440687 | Marketed | Fresenius Kabi Canada Ltd | Sep 2015 |
| SMOFKABIVEN EXTRA NITROGEN (8.5 G) | 02501813 | Marketed | Fresenius Kabi Canada Ltd | May 2021 |
| SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREE (8.5 G) | 02501775 | Marketed | Fresenius Kabi Canada Ltd | Jul 2021 |
| SMOFKABIVEN PERIPHERAL (7.1 G) | 02456206 | Marketed | Fresenius Kabi Canada Ltd | Feb 2017 |
| V-LYTES (WATER SOLUBLE ELECTROLYTE POWDER) (47.562 G) | 02047519 | Marketed | Vetoquinol N A Inc | Dec 1993 |
| V-LYTES HE (WATER SOLUBLE NUTRIENT, ELECTROLYTE POWDER FOR ORAL USE IN CALVES) (149.924 G) | 01957341 | Marketed | Vetoquinol N A Inc | Jul 2007 |
| VETALYTE (25.0 MG) | 02426536 | Marketed | Dmvet Inc | Oct 2014 |
| 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP (3.3 G) | 01927981 | Dormant | B. Braun Medical AG | Jul 2020 |
| 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP (5 G) | 01927558 | Dormant | B. Braun Medical AG | Jul 2017 |
| 5% DEXTROSE AND 0.45% SODIUM CHLORIDE (50 MG) | 00038903 | Dormant | Icu Medical Canada Inc | Jul 2026 |
| 5% DEXTROSE AND 0.9% SODIUM CHLORIDE (50 MG) | 00038946 | Dormant | Icu Medical Canada Inc | Dec 2025 |
| 70% DEXTROSE INJECTION USP (70 G) | 02516179 | Approved | B. Braun Medical AG | May 2021 |
| ACID CONCENTRATE A1220 (74.25 G) | 02381257 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1229 (49.5 G) | 02533901 | Approved | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1251 (49.5 G) | 02533790 | Approved | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1253 (99 G) | 02248823 | Dormant | Chief Medical Supplies Ltd | Jul 2025 |
| ACID CONCENTRATE A1264 (99 G) | 02262509 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1268 (74.25 G) | 02262541 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1269 (74.25 G) | 02262568 | Dormant | Chief Medical Supplies Ltd | Jul 2025 |
| ACID CONCENTRATE A1271 (49.5 G) | 02272520 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1272 (49.5 G) | 02272539 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1273 (49.5 G) | 02272547 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1274 (49.5 G) | 02272555 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1276 (49.5 G) | 02272571 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1278 (49.5 G) | 02272601 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1280 (49.5 G) | 02272636 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1295 (49.49 G) | 02435888 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ADDITIVE SOLUTION FORMULA 3 AS-3 (1.10 G) | 02324393 | Dormant | Terumo Bct, Inc. | Sep 2025 |
| AMINO BOLUSES IMPROVED (2.5 G) | 00319333 | Dormant | Professional Veterinary Laboratories | Oct 2020 |
| AMINO SOLUTION (5 G) | 00319341 | Dormant | Professional Veterinary Laboratories | Oct 2020 |
| AMINO SOLUTION INJ (5 G) | 00395714 | Dormant | Dominion Veterinary Laboratories Ltd. | Oct 2020 |
| AMINOLEAN INJECTION (5 G) | 00506990 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2023 |
| ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A (2.54 G) | 02516675 | Approved | Fresenius Kabi Ag | Jun 2021 |
| AVL CAL-MAG-PHOS (15 %) | 02402041 | Approved | Alberta Veterinary Laboratories Ltd | Feb 2013 |
| BALANCE 1.5% GLUCOSE, 1.75 MMOL/L CALCIUM (16.5 G) | 02261022 | Approved | Fresenius Medical Care Canada Inc | Dec 2019 |
| BALANCE 2.3% GLUCOSE, 1.75 MMOL/L CALCIUM (25 G) | 02261049 | Approved | Fresenius Medical Care Canada Inc | Dec 2019 |
| BALANCE 4.25% GLUCOSE, 1.75 MMOL/L CALCIUM (46.75 G) | 02261030 | Approved | Fresenius Medical Care Canada Inc | Dec 2019 |
| CAL MAG K SOLUTION (25 %) | 00468959 | Dormant | Mtc Pharmaceuticals | Jul 2018 |
| CAL-PLUS (15 %) | 01960873 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2023 |
| CALF-QUENCH (41.734 G) | 02495767 | Approved | Dominion Veterinary Laboratories Ltd. | Jan 2020 |
| CALPHOS INJECTION LIQ (75 G) | 00654612 | Dormant | Rafter 8 Products Inc | Jun 2022 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (1.5 G) | 02453010 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (4.25 G) | 02453029 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (1.5 G) | 02453037 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (4.25 G) | 02453045 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (2.5 G) | 02472880 | Approved | Chief Medical Supplies Ltd | Feb 2018 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (2500 MG) | 02473747 | Approved | Chief Medical Supplies Ltd | Mar 2018 |
| CITRASATE C0125 (49.50 G) | 02366533 | Dormant | Chief Medical Supplies Ltd | Jun 2021 |
| CITRASATE C10125 (49.5 G) | 02325640 | Approved | Chief Medical Supplies Ltd | Apr 2009 |
| CITRASATE C1125 (49.5 G) | 02366541 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C1150 (49.5 G) | 02366592 | Dormant | Chief Medical Supplies Ltd | Aug 2018 |
| CITRASATE C2125 (49.5 G) | 02366568 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C2150 (49.5 G) | 02366606 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C3125 (49.5 G) | 02366576 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C3150 (49.5 G) | 02366614 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C4125 (49.5 G) | 02366584 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| DEXTROSE CALCIUM GLUCONATE MAGNESIUM PHOS (75 G) | 00308374 | Dormant | Professional Veterinary Laboratories | Oct 2020 |
| DEXTROSE INJECTION USP (500 MG) | 00037974 | Dormant | Icu Medical Canada Inc | May 2025 |
| DEXTROSE INJECTION USP (100 MG) | 00037958 | Dormant | Icu Medical Canada Inc | Apr 2023 |
| DEXTROSE INJECTION USP (700 MG) | 00244988 | Dormant | Icu Medical Canada Inc | Jun 2023 |
| DEXTROSE INJECTION USP (200 MG) | 00037966 | Dormant | Icu Medical Canada Inc | Jul 2025 |
| DEXTROSE INJECTION USP (50 MG) | 02468506 | Approved | Pfizer Canada Ulc | Sep 2017 |
| DEXTROSE PLUS ELECTROLYTES (250 G) | 00308366 | Dormant | Professional Veterinary Laboratories | Oct 2020 |
| EGG SHELL IMPROVER (660 MG) | 00308161 | Dormant | Professional Veterinary Laboratories | Oct 2020 |
| ELECTROLYTE INFUSION STERILE INJECTION (50 G) | 00715654 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2023 |
| H.E.L.P.BICEL (9.90 G) | 02373793 | Dormant | B. Braun Avitum Ag | Jul 2025 |
| HEMASATE ULTRA HS0125 (49.50 G) | 02422557 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS1125 (49.5 G) | 02422573 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS1150 (49.5 G) | 02422565 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS2125 (49.5 G) | 02422581 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS2150 (49.5 G) | 02422409 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS3125 (49.5 G) | 02422603 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS3150 (49.5 G) | 02422611 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS4125 (49.5 G) | 02422417 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMOSATE ULTRA HS0125 (49.5 G) | 02413876 | Approved | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS1150 (49.5 G) | 02413930 | Approved | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS2150 (49.5 G) | 02413957 | Dormant | Chief Medical Supplies Ltd | Jul 2025 |
| HEMOSATE ULTRA HS3150 (49.5 G) | 02413965 | Approved | Chief Medical Supplies Ltd | Jan 2021 |
| LACTATE 1-2-3 INJECTION (25 MG) | 00039306 | Dormant | Icu Medical Canada Inc | Nov 2017 |
| MAG CAL (14.5 %) | 01971247 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2018 |
| NATURALYTE H-228 (49.49 G) | 02327104 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-230 (98.99 G) | 02330180 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-321 (49.49 G) | 02326930 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-407 (49.49 G) | 02327392 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-615 (98.99 G) | 02327473 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Feb 2021 |
| NATURALYTE H-625 (74.28 G) | 02327031 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-630 (74.28 G) | 02330040 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-631 (74.28 G) | 02327090 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-706 (49.49 G) | 02327058 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NORMOSOL-M & 5% DEXTROSE (5 G) | 00039489 | Dormant | Icu Medical Canada Inc | Nov 2017 |
| NORMOSOL-R & 5% DEXTROSE (5 G) | 00039640 | Dormant | Icu Medical Canada Inc | Nov 2017 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 303) (23.1 G) | 02363623 | Dormant | Nxstage Medical, Inc. | May 2020 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305) (23.1 G) | 02363658 | Dormant | Nxstage Medical, Inc. | May 2020 |
| POTASSIUM CHLORIDE 20 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE (3.3 G) | 00472085 | Dormant | Icu Medical Canada Inc | Oct 2023 |
| POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE (5 G) | 00466697 | Dormant | Icu Medical Canada Inc | Apr 2023 |
| POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.225% SODIUM CHLORIDE (5 G) | 00466689 | Dormant | Icu Medical Canada Inc | Nov 2018 |
| POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE (5 G) | 00466670 | Dormant | Icu Medical Canada Inc | Mar 2023 |
| POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE (5 G) | 00606820 | Dormant | Icu Medical Canada Inc | Apr 2023 |
| POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE (5 G) | 00603244 | Dormant | Icu Medical Canada Inc | Oct 2023 |
| POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE (5 G) | 02299135 | Dormant | Icu Medical Canada Inc | Sep 2022 |
| REVIBE (43.238 G) | 00859613 | Dormant | Phibro Animal Health Corporation | May 2026 |
| REVIBE H.E. (152 G) | 00890006 | Dormant | Phibro Animal Health Corporation | May 2026 |
| SELECTBAG ONE (AX 050 G) (220 G) | 02414724 | Dormant | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 200 G) (220 G) | 02414848 | Dormant | Vantive Ulc | Jul 2024 |
| SELECTBAG ONE (AX 2550 G) (220 G) | 02415518 | Approved | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 275 G) (220 G) | 02414899 | Dormant | Vantive Ulc | May 2024 |
| SOLYTES POWDER (41.734 G) | 02542412 | Approved | Alberta Veterinary Laboratories Ltd | Oct 2023 |
| SUPERCAL INJ (75 G) | 00260096 | Dormant | Dominion Veterinary Laboratories Ltd. | Oct 2020 |
| SUPERDEX 50% INJ (250 G) | 00260118 | Dormant | Dominion Veterinary Laboratories Ltd. | Oct 2020 |
| SURVIVE BRAND ENERGY PASTE FOR NEONATAL PIGLETS (16.75 %) | 02192411 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2018 |
| TQM ACID CONCENTRATE A1280 (49.5 G) | 02464527 | Approved | Tqm Enterprises Limited | Jun 2017 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.2% SODIUM CHLORIDE INJECTION USP (5 G) | 00503142 | Cancelled Post Market | Baxter Corporation | Jul 2016 |
| 0.15% POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.30% SODIUM CHLORIDE INJECTION (3.3 G) | 01931741 | Cancelled Post Market | B. Braun Medical AG | Jun 2022 |
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.33% SODIUM CHLORIDE INJECTION USP (5 G) | 01931601 | Cancelled Post Market | B. Braun Medical AG | Jul 2018 |
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION (5 G) | 01931547 | Cancelled Post Market | B. Braun Medical AG | Mar 2023 |
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION (5 G) | 01931644 | Cancelled Post Market | B. Braun Medical AG | Mar 2023 |
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP (5 G) | 01931539 | Cancelled Post Market | B. Braun Medical AG | Mar 2023 |
| 0.30% POTASSIUM CHLORIDE IN 5% DEXTROSE (5 G) | 01967770 | Cancelled Post Market | B. Braun Medical AG | Jul 2017 |
| 0.30% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION (5 G) | 01931571 | Cancelled Post Market | B. Braun Medical AG | Mar 2023 |
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION USP (50 MG) | 00478288 | Cancelled Post Market | Hospira Healthcare Corporation | Apr 2019 |
| 10% DEXTRAN 40 IN 5% DEXTROSE INJECTION (5 %) | 01924249 | Cancelled Post Market | B. Braun Medical AG | Dec 2018 |
| 10% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP (10 G) | 01927922 | Cancelled Post Market | B. Braun Medical AG | Dec 2018 |
| 10% DEXTROSE INJECTION, USP (10 G) | 02014823 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 100GM GLUCOSE TOLERANCE DRINK (10 G) | 02003694 | Cancelled Post Market | Criterion Sciences | Nov 1999 |
| 13.3% DEXTROSE INJECTION, USP (13.3 G) | 02015072 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE (10 G) | 02143267 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE CLINIMIX (10 G) | 02013975 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 2.5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 10% DEXTROSE QUICKMIX (10 G) | 02014106 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |